vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and BCB BANCORP INC (BCBP). Click either name above to swap in a different company.

BCB BANCORP INC is the larger business by last-quarter revenue ($26.2M vs $23.1M, roughly 1.1× ADC Therapeutics SA). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs 13.1%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs 1.8%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

ADCT vs BCBP — Head-to-Head

Bigger by revenue
BCBP
BCBP
1.1× larger
BCBP
$26.2M
$23.1M
ADCT
Growing faster (revenue YoY)
ADCT
ADCT
+23.2% gap
ADCT
36.4%
13.1%
BCBP
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
1.8%
BCBP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADCT
ADCT
BCBP
BCBP
Revenue
$23.1M
$26.2M
Net Profit
$-12.0M
Gross Margin
Operating Margin
-77.7%
-71.9%
Net Margin
-49.7%
Revenue YoY
36.4%
13.1%
Net Profit YoY
-467.6%
EPS (diluted)
$0.04
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
BCBP
BCBP
Q4 25
$23.1M
$26.2M
Q3 25
$15.8M
$26.5M
Q2 25
$18.1M
$25.2M
Q1 25
$17.4M
$23.8M
Q4 24
$16.9M
$23.1M
Q3 24
$18.0M
$26.2M
Q2 24
$17.0M
$20.4M
Q1 24
$17.8M
$25.3M
Net Profit
ADCT
ADCT
BCBP
BCBP
Q4 25
$-12.0M
Q3 25
$-41.0M
$4.3M
Q2 25
$-56.6M
$3.6M
Q1 25
$-38.6M
$-8.3M
Q4 24
$3.3M
Q3 24
$-44.0M
$6.7M
Q2 24
$-36.5M
$2.8M
Q1 24
$-46.6M
$5.9M
Operating Margin
ADCT
ADCT
BCBP
BCBP
Q4 25
-77.7%
-71.9%
Q3 25
-196.6%
21.9%
Q2 25
-244.1%
19.9%
Q1 25
-163.5%
-49.2%
Q4 24
-191.8%
19.9%
Q3 24
-197.4%
35.7%
Q2 24
-170.5%
19.5%
Q1 24
-188.3%
33.0%
Net Margin
ADCT
ADCT
BCBP
BCBP
Q4 25
-49.7%
Q3 25
-260.1%
16.1%
Q2 25
-313.2%
14.2%
Q1 25
-221.8%
-35.0%
Q4 24
14.1%
Q3 24
-244.1%
25.5%
Q2 24
-214.6%
13.8%
Q1 24
-261.1%
23.2%
EPS (diluted)
ADCT
ADCT
BCBP
BCBP
Q4 25
$0.04
$-0.73
Q3 25
$-0.30
$0.22
Q2 25
$-0.50
$0.18
Q1 25
$-0.36
$-0.51
Q4 24
$-0.26
$0.17
Q3 24
$-0.42
$0.36
Q2 24
$-0.38
$0.14
Q1 24
$-0.56
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
BCBP
BCBP
Cash + ST InvestmentsLiquidity on hand
$261.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$304.3M
Total Assets
$323.1M
$3.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
BCBP
BCBP
Q4 25
$261.3M
Q3 25
$234.7M
Q2 25
$264.6M
Q1 25
$194.7M
Q4 24
$250.9M
Q3 24
$274.3M
Q2 24
$300.1M
Q1 24
$234.3M
Stockholders' Equity
ADCT
ADCT
BCBP
BCBP
Q4 25
$-185.8M
$304.3M
Q3 25
$-238.2M
$318.5M
Q2 25
$-199.2M
$315.7M
Q1 25
$-238.2M
$314.7M
Q4 24
$-202.6M
$323.9M
Q3 24
$-171.9M
$328.1M
Q2 24
$-131.7M
$320.7M
Q1 24
$-194.4M
$320.1M
Total Assets
ADCT
ADCT
BCBP
BCBP
Q4 25
$323.1M
$3.3B
Q3 25
$289.8M
$3.4B
Q2 25
$321.6M
$3.4B
Q1 25
$272.5M
$3.5B
Q4 24
$322.0M
$3.6B
Q3 24
$349.1M
$3.6B
Q2 24
$371.8M
$3.8B
Q1 24
$308.0M
$3.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
BCBP
BCBP
Operating Cash FlowLast quarter
$-31.1M
$35.9M
Free Cash FlowOCF − Capex
$34.9M
FCF MarginFCF / Revenue
133.3%
Capex IntensityCapex / Revenue
0.0%
4.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$58.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
BCBP
BCBP
Q4 25
$-31.1M
$35.9M
Q3 25
$-29.6M
$8.7M
Q2 25
$-24.1M
$10.3M
Q1 25
$-56.3M
$5.0M
Q4 24
$-21.9M
$67.7M
Q3 24
$-25.0M
$43.5M
Q2 24
$-32.8M
$8.1M
Q1 24
$-44.1M
$8.3M
Free Cash Flow
ADCT
ADCT
BCBP
BCBP
Q4 25
$34.9M
Q3 25
$8.5M
Q2 25
$10.2M
Q1 25
$-56.6M
$4.7M
Q4 24
$-21.9M
$66.5M
Q3 24
$-25.3M
$43.4M
Q2 24
$-32.9M
$8.1M
Q1 24
$-44.6M
$8.1M
FCF Margin
ADCT
ADCT
BCBP
BCBP
Q4 25
133.3%
Q3 25
32.0%
Q2 25
40.4%
Q1 25
-325.2%
19.8%
Q4 24
-129.8%
287.5%
Q3 24
-140.2%
166.0%
Q2 24
-193.0%
39.6%
Q1 24
-250.0%
32.3%
Capex Intensity
ADCT
ADCT
BCBP
BCBP
Q4 25
0.0%
4.0%
Q3 25
0.0%
1.1%
Q2 25
0.0%
0.6%
Q1 25
1.5%
1.2%
Q4 24
0.5%
5.3%
Q3 24
1.2%
0.3%
Q2 24
0.2%
0.2%
Q1 24
3.0%
0.6%
Cash Conversion
ADCT
ADCT
BCBP
BCBP
Q4 25
Q3 25
2.05×
Q2 25
2.90×
Q1 25
Q4 24
20.70×
Q3 24
6.53×
Q2 24
2.88×
Q1 24
1.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons